Overview
BAY 77-1931 Long-term Extension From Phase II Study
Status:
Completed
Completed
Trial end date:
2008-05-01
2008-05-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
A long-term study of BAY77-1931 (lanthanum carbonate) for hyperphosphatemia in patients undergoing hemodialysisPhase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Bayer
Criteria
Inclusion Criteria:- Undergoing hemodialysis 3 times per week for chronic renal failure for the previous 3
consecutive months at least
Exclusion Criteria:
- Pre-dialysis serum phosphate levels of 10.0mg/dL during the washout period